Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/SolasCure

SolasCure

Series B
Cambridge, UKMar 2023
Healthtech

SolasCure raised €12M in a Series B round in Mar 2023. The company is based in Cambridge, UK. Investors in the round: BRAIN Biotech, EVA Pharma, Jonathan Milner and 2 others. Data as of Nov 2026.

← SolasCure
Amount raised
€12M
€12,412,034
Native amount
10,900,000 GBP
Stage
Series B
series b
Investors
5

Provenance & confidence

High confidence
Amount
10,900,000 GBP
ECB-at-date → €12M · rate 0.87818 on 2023-03-27
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named
BRAIN BiotechEVA PharmaJonathan MilnerSeneca PartnersWealth Club
Date
Mar 2023
Round type
series b
Amount (EUR)
€12M

Other rounds

same company

Related news